The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression Relapse

Sponsor
University of Denver (Other)
Overall Status
Completed
CT.gov ID
NCT01145872
Collaborator
Stanford University (Other), University of Colorado, Boulder (Other)
92
1
2
33
2.8

Study Details

Study Description

Brief Summary

This research proposal is intended to elucidate the efficacy and mechanisms underlying Mindfulness Based Cognitive Therapy (MBCT) in a population in remission from recurrent Major Depressive Disorder (MDD). The first objective of the study is to replicate previous studies' findings of MBCT's effects on decreasing depressive symptoms and depression relapse rates. However, this proposal aims to make a novel contribution to the literature by using a randomized, controlled design, and comparing the effects of MBCT to an active control condition (ACC). The use of a well-designed ACC will enable us to control for confounding variables such as social support and expected outcomes, thus allowing us to determine whether elements specific to MBCT lead to its salutary effects (Aim 1). Previous MBCT studies have largely relied on self-report measurement methodologies, limiting valid conclusions about the nature of MBCT. Further, few studies have examined the mechanisms underlying effects of MBCT on depressive symptoms and relapse. Theoretical considerations and preliminary empirical evidence suggest emotional, physiological, and cognitive functioning to be promising mechanisms of MBCT. Therefore, the investigators propose to assess each of these potential mechanisms of MBCT using self-report, autonomic physiological, and reaction time tasks (Aim 2). Collectively, these aims are expected to strengthen the evidence base for MBCT while cultivating a scientific model for its effects and mechanisms on decreasing depressive symptoms and depression relapse rates.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness Based Cognitive Therapy
  • Behavioral: Health Enhancement Program
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
92 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Effects and Mechanisms of MBCT on Depressive Symptoms and Depression Relapse
Study Start Date :
Jul 1, 2010
Actual Primary Completion Date :
May 1, 2012
Actual Study Completion Date :
Apr 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mindfulness Based Cognitive Therapy

Behavioral: Mindfulness Based Cognitive Therapy

Active Comparator: Health Enhancement Program

Behavioral: Health Enhancement Program

Outcome Measures

Primary Outcome Measures

  1. Depression Relapse [1 year]

Secondary Outcome Measures

  1. Depressive Symptoms [1 Year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • must comprehend English well

  • be 18-55 years of age

  • meet enhanced DSM-IV criteria for remission of MDD, recurrent and have a history of three or more previous episodes of DSM-IV major depression in the absence of a history of mania or hypomania

  • at least one of those episodes was within the past two years

  • participant must be in remission and if on antidepressant medication (ADM), they must be on a stable dose with no change in type or amount for past 12 weeks or participants must be off ADM at T1 for at least the preceding 12 weeks

  • have, at screening assessment, residual depressive symptoms indicated by a Beck Depression Inventory-II (BDI-II;[72]) score between 6-19.

Exclusion Criteria:
  • bipolar disorder

  • schizophrenia or borderline personality disorder

  • current suicidal thoughts and/or suicide attempt in last two months

  • current anxiety disorder if it constitutes the predominant aspect of the clinical presentation and requires primary treatment not offered in the project

  • substance abuse or dependence within last three months

  • dementia or subnormal intellectual potential

  • current obsessive-compulsive disorder

  • current eating disorder

  • history of previous mindfulness training or more than eight lifetime sessions of CBT

  • current use of psychotherapy or counseling

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Denver Denver Colorado United States 80208

Sponsors and Collaborators

  • University of Denver
  • Stanford University
  • University of Colorado, Boulder

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amanda Shallcross, Post-Doctoral Researcher, University of Denver
ClinicalTrials.gov Identifier:
NCT01145872
Other Study ID Numbers:
  • F32AT004879-01A2
First Posted:
Jun 17, 2010
Last Update Posted:
Dec 2, 2014
Last Verified:
Dec 1, 2014
Keywords provided by Amanda Shallcross, Post-Doctoral Researcher, University of Denver
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 2, 2014